Covid-19: Moderna vaccine is nearly 95% effective, trial involving high risk and elderly people shows
Reads0
Chats0
TLDR
The UK government has secured five million doses of the covid-19 vaccine candidate mRNA-1273 from US biotech company Moderna after interim analysis of its phase III trial showed it was 94.5% effective.Abstract:
The UK government has secured five million doses of the covid-19 vaccine candidate mRNA-1273 from US biotech company Moderna after interim analysis of its phase III trial showed it was 94.5% effective.
If the vaccine meets standards of safety and effectiveness and is approved by the medicines regulator, the vaccine could be delivered to the UK and Europe as early as spring 2021 with the potential to procure more doses next year, a government statement said.
The trial’s Data Safety Monitoring Board—which was appointed by the US National Institute of Health—carried out the analysis based on 95 covid-19 cases, of which 90 were observed in the placebo group and five were reported in the vaccine group.
The trial enrolled more than 30 000 US participants, including 7000 aged over 65 and 5000 under 65 with high risk chronic diseases. More than one third (37%) of the trial …read more
Citations
More filters
Journal ArticleDOI
High Rates of COVID-19 Vaccine Hesitancy and Its Association with Conspiracy Beliefs: A Study in Jordan and Kuwait among Other Arab Countries
Malik Sallam,Malik Sallam,Deema Dababseh,Huda Eid,Kholoud Al-Mahzoum,Ayat Al-Haidar,Duaa Taim,Alaa’ Yaseen,Nidaa A. Ababneh,Faris G. Bakri,Azmi Mahafzah +10 more
TL;DR: In this paper, the authors assess the attitudes towards the prospective COVID-19 vaccines among the general public in Jordan, Kuwait and other Arab countries, and assess the association between COVID19 vaccine acceptance and conspiracy beliefs.
Journal ArticleDOI
Understanding Drivers of Coronavirus Disease 2019 Vaccine Hesitancy Among Blacks.
Florence Momplaisir,Florence Momplaisir,Norrisa Haynes,Norrisa Haynes,Hervette Nkwihoreze,Maria N. Nelson,Rachel M. Werner,Rachel M. Werner,John B. Jemmott +8 more
TL;DR: The authors conducted focus groups with black barbershop and salon owners living in zip codes of elevated COVID-19 prevalence to assess their attitudes, beliefs, and norms around a COVID19 vaccine.
Journal ArticleDOI
Covid-19: Where are we on vaccines and variants?
TL;DR: Mahase as mentioned in this paper reports on the latest developments in vaccines, variants, and diplomacy nearly a year after the WHO declared the covid-19 pandemic, and Elisabeth Mahase reports on vaccine variants, variants and diplomacy.
Journal ArticleDOI
Viral Pandemics of the Last Four Decades: Pathophysiology, Health Impacts and Perspectives.
Shubhadeep Roychoudhury,Anandan Das,Pallav Sengupta,Sulagna Dutta,S Roychoudhury,S Roychoudhury,Arun Paul Choudhury,A. B. Fuzayel Ahmed,Saumendra Kumar Bhattacharjee,Petr Slama +9 more
TL;DR: Age- and gender-based characterizations suggest that SARS-CoV-2 resembles SARS/MERS/SARS with regard to higher fatality rates in males, and in the older population with comorbidities, to address the immediate and long-term health consequences.
Journal ArticleDOI
Flavonoids are promising safe therapy against COVID-19.
Moza Mohamed Alzaabi,Rania Hamdy,Rania Hamdy,Naglaa S. Ashmawy,Naglaa S. Ashmawy,Alshaimaa M. Hamoda,Alshaimaa M. Hamoda,Fatemah Alkhayat,Neda Naser Khademi,Sara Mahmoud Abo Al Joud,Ali El-Keblawy,Sameh S. M. Soliman +11 more
TL;DR: In this paper, the potential inhibitory mechanisms of flavonoids against SARS-CoV-2 infection and their significant immunomodulatory activities were mapped and compared to elect major flavonoid with a promising role in the current pandemic.
References
More filters
Journal ArticleDOI
Covid-19: Vaccine candidate may be more than 90% effective, interim results indicate
TL;DR: A vaccine candidate developed by Pfizer and BioNTech may be more than 90% effective in preventing covid-19 in participants without prior infection, the first interim analysis of the phase III trial shows.
Related Papers (5)
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.
Fernando P. Polack,Stephen J. Thomas,Nicholas Kitchin,Judith Absalon,Alejandra Gurtman,Stephen Lockhart,John L. Perez,Gonzalo Pérez Marc,Edson D. Moreira,Cristiano Zerbini,Ruth Bailey,Kena A. Swanson,Satrajit Roychoudhury,Kenneth Koury,Ping Li,Warren Kalina,David A. Cooper,Robert W. Frenck,Laura L. Hammitt,Özlem Türeci,Haylene Nell,Axel Schaefer,Serhat Ünal,Dina B. Tresnan,Susan Mather,Philip R. Dormitzer,Ugur Sahin,Kathrin U. Jansen,William C. Gruber +28 more
Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK.
Merryn Voysey,Clemens Sac.,Shabir A. Madhi,Lily Yin Weckx,P M Folegatti,Parvinder K. Aley,Brian Angus,Vicky L. Baillie,Shaun Barnabas,Q E Bhorat,S Bibi,Carmen Briner,P Cicconi,Andrea M. Collins,R Colin-Jones,Clare L. Cutland,Thomas C. Darton,Keertan Dheda,Duncan Cja.,Emary Krw.,Katie J. Ewer,Lee Fairlie,Saul N. Faust,Shuo Feng,Daniela M. Ferreira,Adam Finn,Anna Goodman,Catherine M. Green,Christopher A Green,Paul T. Heath,Christopher Hill,Helen Hill,Ian Hirsch,Hodgson Shc.,Allen Izu,S Jackson,D Jenkin,Joe Ccd.,S Kerridge,Anthonet Koen,Gaurav Kwatra,Rajeka Lazarus,Alison M. Lawrie,A Lelliott,Vincenzo Libri,Patrick J. Lillie,R Mallory,Mendes Ava.,Eveline Pipolo Milan,Angela M. Minassian,Alastair McGregor,Hazel Morrison,Y Mujadidi,Amit J Nana,P J O’Reilly,S D Padayachee,A Pittella,E Plested,Katrina M Pollock,M N Ramasamy,S Rhead,Alexandre Vargas Schwarzbold,Nisha Singh,Andrew Smith,R Song,Matthew D. Snape,Eduardo Sprinz,Rebecca K. Sutherland,R Tarrant,E. Thomson,M E Török,Mark Toshner,Turner Dpj.,Johan Vekemans,Tonya Villafana,Watson Mee.,C J Williams,Alexander D. Douglas,Hill Avs.,Teresa Lambe,Sarah C. Gilbert,Andrew J. Pollard +81 more
Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine.
Lindsey R. Baden,Hana M. El Sahly,Brandon Essink,Karen L. Kotloff,Sharon E. Frey,Rick Novak,David Diemert,Stephen A. Spector,Nadine Rouphael,C. Buddy Creech,John W McGettigan,Shishir Khetan,Nathan Segall,Joel Solis,Adam Brosz,Carlos Fierro,Howard J. Schwartz,Kathleen M. Neuzil,Lawrence Corey,Peter B. Gilbert,Holly Janes,Dean Follmann,Mary A. Marovich,John R. Mascola,Laura Polakowski,Julie E. Ledgerwood,Barney S. Graham,Hamilton Bennett,Rolando Pajon,Conor Knightly,Brett Leav,Weiping Deng,Honghong Zhou,Shu Liang Han,Melanie Ivarsson,Jacqueline Miller,Tal Z Zaks +36 more